Determination of the Stabilities of New Quinazoline Derivatives by HPLC

References

• Braun , J. M. 1993 . SR 4233 (Tirapazamina): a new anticancer drug exploiting hypoxia solid tumors . Br. J. Cancer , 67 : 1163 – 1170 .
   PubMedGoogle Scholar
• Monge , A. , Palop , J. A. , Lopez De Garin , X. , Senador , V. , Sainz , J. , Narro , S. , Hamilton , E. , Clarke , E. D. , Barker , A. J. and Greenhaw , D. T. 1995 . Hipxia‐selective agents derived from quinoxaline 1,4‐Di‐N‐oxides . J. Med. Chem. , 38 : 1786 – 1792 .
   PubMedGoogle Scholar
• Nunn , A. , Linder , K. and Strauss , H. W. 1995 . Nitroimidazoles and imaging hypoxia . Eur. J. Nuci. Med. , 22 : 265
   PubMedGoogle Scholar
• Cerecotto , H. and Gonzales , M. 2001 . N‐oxides as hypoxia selective cytotoxin . Mini Rev. Med. Chem. , 1 ( 3 ) : 219 – 231 .
   PubMedGoogle Scholar
• Papadopoulou , M. V. , Ji , M. , Rao , M. K. and Bloomer , W. D. 2003 . Reductive metabolism of the nitroimidazole‐based hypoxia‐selective cytotoxin NLCQ‐1 (NSC 709257) . Oncol. Res. , 14 ( 1 ) : 21 – 29 .
   PubMed Web of Science ®Google Scholar
• Mikiciuk‐Olasik , E. , Błaszczak‐Świątkiewicz , K. , Z˙urek , E. , Krajewska , U. , Róz˙alski , M. , Kruszyński , R. and Bartczak , T. J. 2004 . New derivatives of quinazoline and 1,2‐dihydroquinazoline N3–oxide with expected antitumour activity . Arch. Pharm. Pharm. Med. Chem. , 337 : 239
   PubMedGoogle Scholar
• Mikiciuk‐Olasik , E. , Z˙urek , E. , Mikołajczak , R. , Zakrzewska , E. and Błaszczak‐Świątkiewicz , K. 2000 . New derivatives of 2‐(N‐arylmethylideneamine)benzophenone oxime as potential radiopharmaceuticals for brain imaging . Nuclear Med. Rev. , 3 ( 2 ) : 149
   PubMedGoogle Scholar
• Błaszczak‐Świątkiewicz , K. , Mikiciuk‐Olasik , E. and Chomka , A. 2004 . Planar chromatography for new quinazoline derivatives . J. Liq. Chromatogr. & Rel. Technol. , 27 ( 19 ) : 3121
   Web of Science ®Google Scholar